Translate Bio: Translate Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update

(marketscreener.com) -- Entered into a definitive agreement under which Sanofi will acquire, subject to customary conditions to closing, all outstanding shares of Translate Bio with a goal of advancing deployment of mRNA technology across vaccines and therapeutics development -- -- Advanced mRNA infectious disease vaccine programs, including Sanofi...https://www.marketscreener.com/quote/stock/TRANSLATE-BIO-INC-44403605/news/Translate-Bio-Announces-Second-Quarter-2021-Financial-Results-and-Provides-Corporate-Update-36086662/?utm_medium=RSS&utm_content=20210805